Advertisements


Sonoma Pharmaceuticals Reports Third Quarter FY 2020 Financial Results

PETALUMA, Calif., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Quarterly Net Loss Reduced by 53% Compared to Prior Year YTD Net Loss Reduced by 82% Compared to Prior Year Total YTD Revenues of $14.4 Million Lower by 2% Compared to Prior Year S.....»»

Category: earningsSource: benzingaFeb 14th, 2020

Sonoma Pharmaceuticals Reports Second Quarter FY 2020 Financial Results

Quarterly and YTD Reduction in Net Loss Compared to Prior Year PETALUMA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a specialty pharmaceutical company dedicated to identifying, .....»»

Category: earningsSource: benzingaNov 14th, 2019

Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results

Strong Quarter-Over-Quarter Performance 26% Increa.....»»

Category: earningsSource: benzingaAug 13th, 2019

Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 14, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today reported .....»»

Category: earningsSource: benzingaAug 14th, 2020

Ayala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

– New interim data from Phase 2 ACCURACY study of AL101 for the treatment of R/M ACC to be presented at ESMO 2020 – – On track to initiate patient dosing in Phase 2 TENACITY study of AL101 for the treatment of TNBC in 2020 –.....»»

Category: earningsSource: benzingaAug 13th, 2020

Satsuma Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

Complet.....»»

Category: earningsSource: benzingaAug 12th, 2020

Tonix Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights

Preclinical data for TNX-1800, a Vaccine Candidate to Protect Against COVID-19, Expected in Fourth Quarter 2020 Interim Analysis Results for Phase 3.....»»

Category: earningsSource: benzingaAug 10th, 2020

Apellis Pharmaceuticals Reports Second Quarter 2020 Financial Results

Apellis Pharmaceuticals Reports Second Quarter 2020 Financial Results.....»»

Category: dealsSource: nytJul 31st, 2020

ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

SINGAPORE, July 13, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497)), a clinical-stage immunology and oncology focused bioph.....»»

Category: earningsSource: benzingaJul 13th, 2020

Ayala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update

– Completed upsized initial public offering raising a total of $59.1 million in gross proceeds – Current cash balance expect.....»»

Category: earningsSource: benzingaJun 22nd, 2020

Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results

- Conference Call Scheduled May 12, 2020 at 4:30 p.m. ET - - Following Recent Financing Cash Runway to End of 2022 - BERKELEY HEIGHTS, N.J., May 12, 2020 (GLOBE.....»»

Category: earningsSource: benzingaMay 12th, 2020

Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights.....»»

Category: earningsSource: benzingaMay 12th, 2020

Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights

DEVON, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.....»»

Category: earningsSource: benzingaMay 11th, 2020

Avadel Pharmaceuticals Reports First Quarter 2020 Financial Results

Reported positive topline data from the pivotal Phase 3 R.....»»

Category: earningsSource: benzingaMay 11th, 2020

Intercept Pharmaceuticals Reports First Quarter 2020 Financial Results, and Provides Business Update

Intercept Pharmaceuticals Reports First Quarter 2020 Financial Results, and Provides Business Update.....»»

Category: earningsSource: benzingaMay 11th, 2020

ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

SINGAPORE, May 11, 2020.....»»

Category: earningsSource: benzingaMay 11th, 2020

Cipher Pharmaceuticals Reports First Quarter 2020 Financial Results

Earnings per common share increases to $0.10 ($0.13 in Canadian Dollars1) OAKVILLE, ON, May 7, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH).....»»

Category: earningsSource: benzingaMay 7th, 2020

Biohaven Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Business Developments

NEW HAVEN, Conn., May 7, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product ca.....»»

Category: earningsSource: benzingaMay 7th, 2020

EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments.....»»

Category: earningsSource: benzingaMay 6th, 2020

Rhythm Pharmaceuticals Reports First Quarter 2020 Financial Results

-- Completed rolling NDA submission to FDA .....»»

Category: earningsSource: benzingaMay 4th, 2020

Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process Update

SAN DIEGO, May 01, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced f.....»»

Category: earningsSource: benzingaMay 1st, 2020